Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Capper

Showing results (1-10 of 350) with videos related to

Pageof 35
Sort By:
Applied Immunohistochemistry & Molecular Morphology : AIMM|December 14, 2012
Lack of BRAF V600E protein expression in primary central nervous system lymphomaAnna S Berghoff, David Capper, Matthias Preusser
Oncotarget|September 26, 2012
Mutation specific antibodies: tool or dinosaur?Andreas von Deimling, Felix Sahm, David Capper
Acta Neuropathologica|October 30, 2007
Pitfalls in the assessment of MGMT expression and in its correlation with survival in diffuse astrocytomas: proposal of a feasible immunohistochemical approachDavid Capper, Michel Mittelbronn, Richard Meyermann, et al.
The American Journal of Emergency Medicine|March 8, 2014
Secondary hematoma expansion in intracerebral hemorrhage during rivaroxaban therapyJan C Purrucker, David Capper, Lars Behrens, et al.
Clinical Neurology and Neurosurgery|May 6, 2015
Risk factors for glioblastoma therapy associated complicationsGenevieve Ening, Fransiska Osterheld, David Capper, et al.
Neuro Endocrinology Letters|May 2, 2006
ACTH- and prolactin-producing pituitary gland microadenoma with biphasic features of atypia and intermediate filament expressionMichel Mittelbronn, Tsambika Psaras, David Capper, et al.
Clinical Neuropathology|March 6, 2012
Clinical neuropathology practice news 2-2012: BRAF V600E testingDavid Capper, Anna-Sophie Berghoff, Andreas von Deimling, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|July 29, 2014
Spinal metastasis of gliosarcoma: array-based comparative genomic hybridization for confirmation of metastatic spreadGenevieve Schindler, David Capper, Andrey Korshunov, et al.
Acta Neuropathologica|October 3, 2009
Monoclonal antibody specific for IDH1 R132H mutationDavid Capper, Hanswalter Zentgraf, Jörg Balss, et al.
Journal of the American Academy of Dermatology|August 15, 2012
Detection of BRAF V600E mutations in skin metastases of malignant melanoma by monoclonal antibody VE1Alexander Skorokhod, David Capper, Andreas von Deimling, et al.
Pageof 35

Showing results (1-10 of 350) with videos related to

Sort By:
Pageof 35
Applied Immunohistochemistry & Molecular Morphology : AIMM|December 14, 2012
Lack of BRAF V600E protein expression in primary central nervous system lymphomaAnna S Berghoff, David Capper, Matthias Preusser
Oncotarget|September 26, 2012
Mutation specific antibodies: tool or dinosaur?Andreas von Deimling, Felix Sahm, David Capper
Acta Neuropathologica|October 30, 2007
Pitfalls in the assessment of MGMT expression and in its correlation with survival in diffuse astrocytomas: proposal of a feasible immunohistochemical approachDavid Capper, Michel Mittelbronn, Richard Meyermann, et al.
The American Journal of Emergency Medicine|March 8, 2014
Secondary hematoma expansion in intracerebral hemorrhage during rivaroxaban therapyJan C Purrucker, David Capper, Lars Behrens, et al.
Clinical Neurology and Neurosurgery|May 6, 2015
Risk factors for glioblastoma therapy associated complicationsGenevieve Ening, Fransiska Osterheld, David Capper, et al.
Neuro Endocrinology Letters|May 2, 2006
ACTH- and prolactin-producing pituitary gland microadenoma with biphasic features of atypia and intermediate filament expressionMichel Mittelbronn, Tsambika Psaras, David Capper, et al.
Clinical Neuropathology|March 6, 2012
Clinical neuropathology practice news 2-2012: BRAF V600E testingDavid Capper, Anna-Sophie Berghoff, Andreas von Deimling, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|July 29, 2014
Spinal metastasis of gliosarcoma: array-based comparative genomic hybridization for confirmation of metastatic spreadGenevieve Schindler, David Capper, Andrey Korshunov, et al.
Acta Neuropathologica|October 3, 2009
Monoclonal antibody specific for IDH1 R132H mutationDavid Capper, Hanswalter Zentgraf, Jörg Balss, et al.
Journal of the American Academy of Dermatology|August 15, 2012
Detection of BRAF V600E mutations in skin metastases of malignant melanoma by monoclonal antibody VE1Alexander Skorokhod, David Capper, Andreas von Deimling, et al.
Pageof 35